Your browser doesn't support javascript.
A strategic approach to COVID-19 vaccine R&D.
Corey, Lawrence; Mascola, John R; Fauci, Anthony S; Collins, Francis S.
  • Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Mascola JR; Departments of Medicine and Lab Medicine, University of Washington, Seattle, WA 98195, USA.
  • Fauci AS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Collins FS; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. afauci@niaid.nih.gov.
Science ; 368(6494): 948-950, 2020 05 29.
Article in English | MEDLINE | ID: covidwho-679163
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Public-Private Sector Partnerships / Pandemics / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Animals / Humans Country/Region as subject: North America Language: English Journal: Science Year: 2020 Document Type: Article Affiliation country: Science.abc5312

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Public-Private Sector Partnerships / Pandemics / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Animals / Humans Country/Region as subject: North America Language: English Journal: Science Year: 2020 Document Type: Article Affiliation country: Science.abc5312